Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2021-10-27 2021-10-27
Drug Identification Number 02421496 02421496
Brand name PMS-LEVOCARB CR PMS-LEVOCARB CR
Common or Proper name LEVOCARB LEVOCARB
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients LEVODOPA CARBIDOPA LEVODOPA CARBIDOPA
Strength(s) 200MG 50MG 200MG 50MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N04BA N04BA
ATC description DOPAMINERGIC AGENTS DOPAMINERGIC AGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-06-15 2020-06-15
Actual discontinuation date 2020-06-15 2020-06-15
Remaining supply date 2020-06-12 2020-06-12
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments